Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04861844 · ClinicalTrials.gov registry record · NA

Tracking Mood and Language Change Across a Phone-based Mindfulness Intervention

A NA study, sponsored by Northwestern University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT04861844: Clinical Trial NA study, sponsored by Northwestern University.

NCT04861844 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04861844, a NA study, was terminated before completion, sponsored by Northwestern University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The objective of this study is to administer a brief, phone(voice)-based training program in mindfulness (or control task of active listening to narrated articles) to older adults who receive primary care services at NM. Older adults represent a population that is at risk for depression and anxiety, especially during the current COVID-19 pandemic and the social isolation it entails. Many older adults also possess relatively low access to application-based mindfulness training opportunities. The monitoring aims are: 1. To determine whether the experimental intervention (mindfulness training) performs better than a control task (active listening) in improving mood assessed using the Profile of Mood States (POMS) and/or anxiety assessed using the State-Trait Anxiety Inventory (STAI). 2. To determine whether the experimental and/or control intervention is associated with quantified changes in language use (e.g., frequency of negative word use), which may or may not also be associated with changes in mood and anxiety.

Primary Outcome

The Profile of Mood States (POMS) is a widely used instrument that measures mood using a 65-item questionnaire with each item rated using a response scale of five categories ranging from "not at all" to "very strong". Higher score indicates worse mood.

Interventions

  • BEHAVIORAL mindfulness training
  • BEHAVIORAL active listening

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2021-04-01
Est. Completion 2023-03-22
Phase NA
Northwestern University

1,209 total trials

Why NCT04861844 stopped before completion

NCT04861844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which mindfulness training is the first listed.

NCT04861844 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04861844 about?

NCT04861844 is a clinical study titled "Tracking Mood and Language Change Across a Phone-based Mindfulness Intervention". The objective of this study is to administer a brief, phone(voice)-based training program in mindfulness (or control task of active listening to narrated articles) to older adults who receive primary care services at NM. Older adults represent a population that is at risk for depression and anxiety,...

What is the current status of trial NCT04861844?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-04-01. Estimated completion is 2023-03-22.

What interventions are being tested in trial NCT04861844?

The interventions under investigation include: mindfulness training (BEHAVIORAL), active listening (BEHAVIORAL).

Who is sponsoring clinical trial NCT04861844?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04861844's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04861844, the US trial registry maintained by the National Library of Medicine. NCT04861844 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.